Healthcare -
Biotechnology - NASDAQ - US
$ 8.32
2.4 %
$ 316 M
Market Cap
14.0
P/E
TRDA - LONG-TERM DEBT
Long-term Debt TRDA - Entrada Therapeutics, Inc.
103 M
LAST VALUE
142.75%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR